Works matching DE "IDARUBICIN"

Results: 175
    1
    2
    3
    4
    5

    Ratifying the efficacy and safety of intensive induction chemotherapy for acute myeloid leukaemia by the Australasian Leukaemia & Lymphoma Group consensus approach.

    Published in:
    Internal Medicine Journal, 2025, v. 55, n. 5, p. 749, doi. 10.1111/imj.70010
    By:
    • Tedjaseputra, Aditya;
    • Tey, Amanda;
    • Nalpantidis, Anastasios;
    • Grigoriadis, George;
    • Fleming, Shaun;
    • Vilcassim, Shahla;
    • Fedele, Pasquale L.;
    • Low, Michael Sze Yuan;
    • Yeh, Paul;
    • Gilbertson, Michael;
    • Bennett, Ashwini;
    • Gregory, Gareth P.;
    • Oh, Danielle;
    • Gairns, Donna;
    • Kaplan, Zane;
    • Chunilal, Sanjeev D.;
    • Brown, Susan;
    • Opat, Stephen;
    • Chua, Chong C.;
    • Shortt, Jake
    Publication type:
    Article
    6
    7
    8
    9
    10
    11

    A randomised phase II study of azacitidine (AZA) alone or with Lenalidomide (LEN), Valproic acid (VPA) or Idarubicin (IDA) in higher‐Risk MDS or low blast AML: GFM's "pick a winner" trial, with the impact of somatic mutations.

    Published in:
    British Journal of Haematology, 2022, v. 198, n. 3, p. 535, doi. 10.1111/bjh.18193
    By:
    • Adès, Lionel;
    • Duployez, Nicolas;
    • Guerci‐Bresler, Agnes;
    • Laribi, Kamel;
    • Peterlin, Pierre;
    • Vey, Norbert;
    • Thepot, Sylvain;
    • Wickenhauser, Stefan;
    • Zerazhi, Hacene;
    • Stamatoullas, Aspassia;
    • Wattel, Eric;
    • Recher, Christian;
    • Toma, Andrea;
    • Dimicoli‐Salazar, Sophie;
    • Braun, Thorsten;
    • Beyne‐Rauzy, Odile;
    • Marolleau, Jean‐Pierre;
    • Cheze, Stéphane;
    • Park, Sophie;
    • Cluzeau, Thomas
    Publication type:
    Article
    12

    A Phase II study of selinexor plus cytarabine and idarubicin in patients with relapsed/refractory acute myeloid leukaemia.

    Published in:
    British Journal of Haematology, 2020, v. 190, n. 3, p. e169, doi. 10.1111/bjh.16804
    By:
    • Fiedler, Walter;
    • Chromik, Joerg;
    • Amberg, Stefanie;
    • Kebenko, Maxim;
    • Thol, Felicitas;
    • Schlipfenbacher, Vera;
    • Christine Wilke, Anne;
    • Modemann, Franziska;
    • Janning, Melanie;
    • Serve, Hubert;
    • Ganser, Arnold;
    • Bokemeyer, Carsten;
    • Theile, Susann;
    • Deppermann, Ute;
    • Kranich, Anne L.;
    • Heuser, Michael
    Publication type:
    Article
    13

    Phase I/II study on cytarabine and idarubicin combined with escalating doses of clofarabine in newly diagnosed patients with acute myeloid leukaemia and high risk for induction failure (AMLSG 17‐10 CIARA trial).

    Published in:
    British Journal of Haematology, 2018, v. 183, n. 2, p. 235, doi. 10.1111/bjh.15546
    By:
    • Krauter, Jürgen;
    • Fiedler, Walter;
    • Schlenk, Richard F.;
    • Paschka, Peter;
    • Thol, Felicitas;
    • Lübbert, Michael;
    • Wattad, Mohammed;
    • Verbeek, Mareike;
    • Könecke, Christian;
    • Neuhaus, Barbara;
    • Papkalla, Armin;
    • Kebenko, Maxim;
    • Janning, Melanie;
    • Döhner, Konstanze;
    • Gaidzik, Verena I.;
    • Becker, Heiko;
    • Greil, Christine;
    • Reimer, Peter;
    • Götze, Katharina S.;
    • Döhner, Hartmut
    Publication type:
    Article
    14
    15
    16

    Clinical characteristics and outcomes in patients with acute promyelocytic leukaemia and hyperleucocytosis.

    Published in:
    British Journal of Haematology, 2015, v. 168, n. 5, p. 646, doi. 10.1111/bjh.13189
    By:
    • Daver, Naval;
    • Kantarjian, Hagop;
    • Marcucci, Guido;
    • Pierce, Sherry;
    • Brandt, Mark;
    • Dinardo, Courtney;
    • Pemmaraju, Naveen;
    • Garcia‐Manero, Guillermo;
    • O'Brien, Susan;
    • Ferrajoli, Alessandra;
    • Verstovsek, Srdan;
    • Popat, Uday;
    • Hosing, Chitra;
    • Anderlini, Paolo;
    • Borthakur, Gautam;
    • Kadia, Tapan;
    • Cortes, Jorge;
    • Ravandi, Farhad
    Publication type:
    Article
    17
    18

    Outpatient bendamustine and idarubicin for upfront therapy of elderly acute myeloid leukaemia/myelodysplastic syndrome: a phase I/II study using an innovative statistical design.

    Published in:
    British Journal of Haematology, 2014, v. 166, n. 3, p. 375, doi. 10.1111/bjh.12905
    By:
    • Lionberger, Jack M.;
    • Pagel, John M.;
    • Sandhu, Vicky K.;
    • Xie, Hu;
    • Shadman, Mazyar;
    • Mawad, Raya;
    • Boehm, Alexandra;
    • Dean, Carol;
    • Shannon‐Dorcy, Kathleen;
    • Scott, Bart L.;
    • Deeg, Hans Joachim;
    • Becker, Pamela S.;
    • Hendrie, Paul C.;
    • Walter, Roland B.;
    • Ostronoff, Fabiana;
    • Appelbaum, Frederick R.;
    • Estey, Elihu H.
    Publication type:
    Article
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50